Journals / Anatolian Current Medical Journal / 2026 / Volume: 8 Issue: 6

Association of the Atherogenic Index of Plasma with metabolic and inflammatory biomarkers: the independent roles of the Triglyceride-Glucose Index, body-mass index, and gender

Fatma Zehra Ağan(HARRAN ÜNİVERSİTESİ)0000-0002-3784-8553
Pages
—
Publication Date
2026-10-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings support the association of AIP with cardiometabolic characteristics while emphasizing the need for cautious interpretation of composite-index relationships.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims: The Atherogenic Index of Plasma (AIP) is a useful marker of atherogenic dyslipidemia and is associated with cardiometabolic risk.
📊
Key Findings & Data:Methods: A total of 239 adults with complete clinical, biochemical, and anthropometric data were included.
💡
Conclusion & Impact:These findings support the association of AIP with cardiometabolic characteristics while emphasizing the need for cautious interpretation of composite-index relationships.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Triglycerides · blood glucose · obesity

Abstract

Aims: The Atherogenic Index of Plasma (AIP) is a useful marker of atherogenic dyslipidemia and is associated with cardiometabolic risk. However, the relative associations of metabolic and inflammatory factors with AIP remain incompletely characterized. This study investigated the associations between AIP and metabolic and inflammatory biomarkers and evaluated factors independently associated with AIP in adults. Methods: A total of 239 adults with complete clinical, biochemical, and anthropometric data were included. AIP was calculated as log10 (triglycerides/HDL-C), and the Triglyceride-Glucose Index (TyG) was used as a surrogate marker of insulin resistance. C-reactive protein (CRP) and ferritin were log transformed. Pearson and triglyceride-controlled partial correlation analyses were performed, followed by multivariable linear regression and a sensitivity analysis replacing TyG with fasting glucose. Results: AIP showed a very strong positive correlation with the TyG index (r=0.825, p<0.001), as well as moderate correlations with body-mass index (BMI) (r=0.427, p<0.001), CRP_log (r=0.239, p<0.001), and ferritin_log (r=0.326, p<0.001). The association between AIP and TyG was substantially attenuated after controlling for triglyceride concentration (partial r=0.380, p<0.001). Similarly, the unadjusted association between AIP and fasting glucose (r=0.189, p=0.003) was no longer statistically significant after triglyceride adjustment (partial r=0.102, p=0.118). In the primary multivariable regression model, TyG showed the largest standardized coefficient (β=0.754, p<0.001), while BMI (β=0.127, p=0.005) and gender (β=-0.162, p<0.001) were also independently associated with AIP. In the sensitivity model replacing TyG with fasting glucose, BMI (β=0.341, p<0.001) and gender (β=-0.294, p<0.001) remained significantly associated with AIP, whereas fasting glucose, CRP_log, and Ferritin_log were not. Conclusion: The strong unadjusted association between AIP and TyG was substantially attenuated after controlling for triglyceride concentration, highlighting the importance of mathematical coupling when interpreting associations between these composite indices. BMI remained independently associated with AIP across alternative model specifications, whereas fasting glucose and inflammatory markers did not show independent statistical associations after multivariable adjustment. These findings support the association of AIP with cardiometabolic characteristics while emphasizing the need for cautious interpretation of composite-index relationships.

🔖

Cite This Article

Ağan, F. Z. (2026). Association of the Atherogenic Index of Plasma with metabolic and inflammatory biomarkers: the independent roles of the Triglyceride-Glucose Index, body-mass index, and gender. Anatolian Current Medical Journal, Volume: 8 Issue: 6. https://ajindex.com/articles/1667859

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (26)

  1. Andraschko LM, Gazi G, Leucuta DC, Popa SL, Chis BA, Ismaiel A. Atherogenic Index ofPlasma in metabolic syndrome: a systematic review and meta-analysis. Medicina (Kaunas). 2025;61(4):611. doi:10.3390/medicina61040611
  2. Lioy B, Webb RJ, Amirabdollahian F. The association between the Atherogenic Index of Plasma and cardiometabolic risk factors: a review. Healthcare (Basel). 2023;11(7):966. doi:10.3390/healthcare11070966
  3. Akgul A, Ikhlef C, Tunca Ç, Aylı MD. Association between metabolic and atherogenic indices and circadian blood pressure patterns in white-coat hypertension. Medicina (Kaunas). 2026;62(2):379. doi:10.3390/medicina62020379
  4. Rashidian P, Mirchandani M, Somu KP, et al. Association between Atherogenic Index of Plasma and various metabolic conditions: an umbrella review on meta-analyses. BMC Cardiovasc Disord. 2025;26(1):41. doi:10.1186/s12872-025-05409-w
  5. Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity: comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347-3351. doi:10.1210/jc.2010-0288
  6. Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, et al. Diagnostic accuracy of the Triglyceride-Glucose Index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020:4678526. doi:10.1155/2020/4678526
  7. Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-Glucose Index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68. doi:10.1186/s12933-022-01511-x
  8. Nabipoorashrafi SA, Seyedi SA, Rabizadeh S, et al. The accuracy of triglyceride-glucose (TyG) index for the screening of metabolic syndrome in adults: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis. 2022;32(12):2677-2688. doi:10.1016/j.numecd.2022.07.024
  9. Erdoğan A, İnan D, Genç Ö, et al. The triglyceride-glucose index might be a better indicator for predicting poor cardiovascular outcomes in chronic coronary syndrome. J Clin Med. 2023;12(19):6201. doi:10.3390/jcm12196201
  10. Lai J, Zhang X, He Y, Liang S. Triglyceride-glucose index and the risk of major adverse cardiovascular events in patients with coronary artery disease: a systematic review and meta-analysis. Medicine (Baltimore). 2025;104(42):e42562. doi:10.1097/MD.0000000000042562
  11. Tamini S, Bondesan A, Caroli D, Marazzi N, Sartorio A. The ability of the Triglyceride-Glucose (TyG) index and modified TyG indexes to predict the presence of metabolic-associated fatty liver disease and metabolic syndrome in a pediatric population with obesity. J Clin Med. 2025;14(7):2341. doi:10.3390/jcm14072341
  12. Gusev E, Sarapultsev A. Atherosclerosis and inflammation: insights from the theory of general pathological processes. Int J Mol Sci. 2023;24(9):7910. doi:10.3390/ijms24097910
  13. Zaidi SUEA, Mohammad A, Ahmad I, et al. Inflammation and cardiovascular risk: a systematic review of high-sensitivity CRP as a prognostic indicator. Cureus. 2026;18(2):e103348. doi:10.7759/cureus.103348
  14. He Q, Yu W, Rao X, et al. Association between the cumulative Atherogenic Index Of Plasma and cardiometabolic multimorbidity: the mediating effects of the TyG index and body-mass index. Lipids Health Dis. 2026;25(1):65. doi:10.1186/s12944-026-02875-9
  15. Karimpour Reyhan S, Yadegar A, Samimi S, et al. Atherogenic Index of Plasma (AIP): the most accurate indicator of overweight and obesity among lipid indices in type 2 diabetes-findings from a cross-sectional study. Endocrinol Diabetes Metab. 2024;7(6):e70007. doi:10.1002/edm2.70007
  16. Soheilifard S, Faramarzi E, Mahdavi R. Association between cardiometabolic phenotypes with Atherogenic Index of Plasma: a cross-sectional study from the Azar cohort population. BMC Cardiovasc Disord. 2025;25:627. doi:10.1186/s12872-025-05043-6
  17. Wu X, Qiu W, Yang H, et al. Associations of the Triglyceride-Glucose Index and Atherogenic Index of Plasma with the severity of new-onset coronary artery disease in different glucose metabolic states. Cardiovasc Diabetol. 2024;23:76. doi:10.1186/s12933-024-02163-9
  18. Yu C, Qiu C, Zhang Q, Wang W, Liu S, Jin Z. Association of Atherogenic Index of Plasma and cardiometabolic index with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018. Cardiovasc Diabetol. 2026;25(1):74. doi:10.1186/s12933-025-03043-6
  19. Yin B, Wu Z, Xia Y, et al. Non-linear association of Atherogenic Index of Plasma with insulin resistance and type 2 diabetes: a cross-sectional study. Cardiovasc Diabetol. 2023;22:157. doi:10.1186/s12933-023-01886-5
  20. Gounden V, Devaraj S, Jialal I. The role of the Triglyceride-Glucose Index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024; 23(1):416. doi:10.1186/s12944-024-02412-6
  21. Zhao Y, Ghaedi A, Azami P, et al. Inflammatory biomarkers in cardiac syndrome X: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2024;24(1):276. doi:10.1186/s12872-024-03939-3
  22. Valenti L, Corradini E, Adams LA, et al. Consensus statement on the definition and classification of metabolic hyperferritinaemia. Nat Rev Endocrinol. 2023;19:299-310. doi:10.1038/s41574-023-00807-6
  23. Liu Y, Guan S, Xu H, Zhang N, Huang M, Liu Z. Inflammation biomarkers are associated with the incidence of cardiovascular disease: a meta-analysis. Front Cardiovasc Med. 2023;10:1175174. doi:10.3389/fcvm.2023.1175174
  24. Yurekli UF, Altunbas R. The relationship between serum ferritin level and insulin resistance in metabolic syndrome. Ulutas Med J. 2023;9(1): 30-34. doi:10.5455/umj.20230119123818
  25. Acton RT, Barton JC, Barton JC. Serum ferritin, insulin resistance, and metabolic syndrome: clinical and laboratory associations in 769 non-Hispanic whites without diabetes mellitus in the HEIRS study. Metab Syndr Relat Disord. 2015;13(2):57-63. doi:10.1089/met.2014.0106
  26. Bouzidi N, Messaoud MB, Maatouk F, Gamra H, Ferchichi S. Relationship between high sensitivity C-reactive protein and angiographic severity of coronary artery disease. J Geriatr Cardiol. 2020;17(5):256-263. doi:10.11909/j.issn.1671-5411.2020.05.003